Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLLU1 antisense RNA 1 (CLLU1-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 12, transcribed from the opposite strand of the CLLU1 gene. It is part of the antisense RNA class, which regulates gene expression by various mechanisms, including interference with transcription or chromatin remodeling. CLLU1-AS1 does not encode a functional protein, but its expression has been linked to chronic lymphocytic leukemia and possibly other malignancies, suggesting a potential, though not well-characterized, regulatory or pathogenic role. Its exact biological and clinical impact remains under active investigation, and there is currently no evidence that it is a direct target of any approved therapeutic drugs[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CLLU1 antisense RNA 1 (CLLU1-AS1).